Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE EFFECT OF NEBULIZED AZITHROMYCIN AS AN ADJUVANT PREVENTIVE THERAPY FOR BRONCHOPULMONARY DYSPLASIA IN PRETERM INFANTS

NCT06584474 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT06584474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06584474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE EFFECT OF NEBULIZED AZITHROMYCIN AS AN ADJUVANT PREVENTIVE THERAPY FOR BRONCHOPULMONARY DYSPLASIA IN PRETERM INFANTS
Lead sponsor
Alexandria University
Phase
Phase 4
Overall status
Completed
Start date
October 2, 2024
Completion date
July 2, 2025
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, premature, ventilation, mechanical